King Luther Capital Management Corp Gsk PLC Transaction History

King Luther Capital Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$42.05 - $47.77 $203,942 - $231,684	4,850 New	4,850 $211,000
Q1 2022 May 11, 2022	SELL	$40.23 - $47.74 $183,408 - $217,646	-4,559 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $177,253 - $206,568	4,559 New	4,559 $201,000
Q4 2020 Feb 10, 2021	SELL	$34.07 - $39.94 $185,919 - $217,952	-5,457 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$38.11 - $42.99 $9,794 - $11,048	-257 Reduced 4.5%	5,457 $205,000
Q2 2020 Aug 12, 2020	SELL	$37.87 - $43.58 $37,832 - $43,536	-999 Reduced 14.88%	5,714 $233,000
Q1 2020 May 13, 2020	SELL	$32.47 - $48.83 $91,208 - $137,163	-2,809 Reduced 29.5%	6,713 $254,000
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $187,488 - $215,388	4,464 Added 88.26%	9,522 $447,000
Q3 2019 Nov 12, 2019	SELL	$40.46 - $43.52 $8,496 - $9,139	-210 Reduced 3.99%	5,058 $216,000
Q1 2019 May 10, 2019	BUY	$38.57 - $42.69 $203,186 - $224,890	5,268 New	5,268 $220,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $76.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on King Luther Capital Management Corp with notifications on news.